ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,565,000 | +78.2% | 20,400 | 0.0% | 0.01% | +66.7% |
| Q3 2020 | $878,000 | -83.4% | 20,400 | -83.3% | 0.00% | -70.0% |
| Q2 2020 | $5,278,000 | +50.9% | 122,200 | +0.5% | 0.01% | +11.1% |
| Q1 2020 | $3,498,000 | -65.2% | 121,600 | -23.2% | 0.01% | -55.0% |
| Q4 2019 | $10,048,000 | +1146.7% | 158,400 | +453.8% | 0.02% | +900.0% |
| Q3 2019 | $806,000 | -43.5% | 28,600 | -63.2% | 0.00% | -66.7% |
| Q1 2019 | $1,426,000 | +109.4% | 77,700 | +41.8% | 0.01% | +100.0% |
| Q4 2018 | $681,000 | +0.6% | 54,800 | +55.2% | 0.00% | +50.0% |
| Q3 2018 | $677,000 | +64.3% | 35,300 | +16.5% | 0.00% | 0.0% |
| Q2 2018 | $412,000 | +172.8% | 30,300 | +44.3% | 0.00% | +100.0% |
| Q1 2018 | $151,000 | +96.1% | 21,000 | 0.0% | 0.00% | – |
| Q4 2017 | $77,000 | – | 21,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
| L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
| Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
| Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
| ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
| First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
| Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
| Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
| Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |